Description
AOD9604 is a modified peptide fragment derived from the C-terminal region of human growth hormone (HGH fragment 176-191). It is widely studied for its potential involvement in lipolysis and fat metabolism pathways without the broader endocrine activity associated with full growth hormone signalling.
AOD9604 does not appear to stimulate insulin-like growth factor pathways in the same manner as traditional growth hormone peptides, making it a subject of interest in metabolic and adipose tissue research environments.
Supplied as a lyophilised peptide powder in sterile laboratory research vials.
Contents: 5mg AOD9604 per vial
For laboratory research use only.
Not intended for human consumption or therapeutic use.
Research investigations have focused on AOD9604 for its interaction with fat-metabolism signalling pathways and adipose tissue regulation, particularly in metabolic research models exploring energy utilisation and lipid mobilisation.
Reviews
There are no reviews yet.